You are here

lupus

AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus

BioSpace

Fri, 03/24/23 - 11:50 am

ulcerative colitis

clinical trials

Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink

Fierce Biotech

Fri, 02/24/23 - 09:27 am

Nektar Therapeutics

rezpegaldesleukin

clinical trials

Gilead, EVOQ Unite on 'Potential Breakthrough' Treatment for RA, Lupus

BioSpace

Tue, 01/3/23 - 10:28 pm

Gilead Sciences

Evoq Therapeutics

rheumatoid arthritis

GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care

Fierce Pharma

Tue, 11/29/22 - 08:29 pm

pharma marketing

Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise

BioSpace

Fri, 09/9/22 - 11:07 am

systemic lupus erythematosus

monoclonal antibodies

clinical trials

Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates

BioSpace

Wed, 08/31/22 - 10:25 am

Aria Pharmaceuticals

idiopathic pulmonary fibrosis

chronic kidney disease

Bristol Myers Squibb, with new positive lupus data in hand, readies TYK2 inhibitor for final test

Fierce Biotech

Wed, 06/1/22 - 09:48 am

Bristol Myers Squibb

deucravacitinib

Seres, Vera Notch Weekend Wins in C.Diff, Lupus Trials

BioSpace

Mon, 05/23/22 - 10:22 am

Seres Therapeutics

clinical trials

Vera Therapeutics

Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA

Fierce Pharma

Fri, 01/28/22 - 11:47 am

Idorsia sets itself up for failure

EP Vantage

Mon, 11/1/21 - 10:57 pm

clinical trials

AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program

Fierce Pharma

Tue, 08/3/21 - 11:13 am

patient advocacy groups

AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo

Fierce Pharma

Mon, 08/2/21 - 11:08 am

systemic lupus erythematosus

GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead

Fierce Pharma

Tue, 07/27/21 - 04:24 pm

DTC advertising

Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate

Yahoo/Zacks.com

Mon, 06/21/21 - 10:54 am

clinical trials

Progentec’s Novel Blood Test Predicts Lupus Flares Up to 12 Weeks Before They Occur

BioSpace

Mon, 09/21/20 - 10:51 am

Progentec Diagnostics

J&J scraps late-stage study testing Stelara for lupus

Reuters

Sat, 06/27/20 - 11:40 pm

clinical trials

AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy

Endpoints

Thu, 06/18/20 - 10:55 am

Alpine Immune Sciences

How a Seattle Genetics cancer drug could help lupus patients with kidney damage

Fierce Biotech

Thu, 04/9/20 - 10:35 am

Seattle Genetics

AstraZeneca lupus drug shows potential, but it may not be enough for FDA

Biopharma Dive

Thu, 12/19/19 - 01:05 pm

GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win

Fierce Pharma

Wed, 12/18/19 - 10:54 am

Pages